Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.156.033)
Received: 1 June 2018
Accepted: 25 January 2019
First Online: 7 February 2019
Authors’ information (optional)
: Not applicable.
: The local Institutional Review Board approved the study protocol (METC2015_079). Written informed consent was obtained from all participants.
: Consent for publication of raw data not obtained, but dataset is fully anonymous.
: ICH – Consultant to Vertex.MGWD – Reports no disclosures.GEJ – Reports no disclosures.MW – Reports no disclosures.BMG – Reports no disclosures.BTPT – Reports no disclosures.SK – Received research grant from Bluebird Bio and is consultant to Vertex, Bluebird Bio and SwanBio Therapeutics.ME – Received research grants from Vertex and Minoryx Therapeutics and is consultant to Vertex and Minoryx Therapeutics.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.